Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Operating Expenses 2010-2025 | UTHR

United Therapeutics annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • United Therapeutics operating expenses for the quarter ending March 31, 2025 were $0.412B, a 28.06% increase year-over-year.
  • United Therapeutics operating expenses for the twelve months ending March 31, 2025 were $1.591B, a 28.12% increase year-over-year.
  • United Therapeutics annual operating expenses for 2024 were $1.5B, a 31.31% increase from 2023.
  • United Therapeutics annual operating expenses for 2023 were $1.143B, a 19.44% increase from 2022.
  • United Therapeutics annual operating expenses for 2022 were $0.957B, a 15.32% decline from 2021.
  
United Therapeutics Annual Operating Expenses
(Millions of US $)
2024 $1,500
2023 $1,143
2022 $957
2021 $1,130
2020 $890
2019 $1,636
2018 $822
2017 $910
2016 $537
2015 $767
2014 $750
2013 $824
2012 $494
2011 $425
2010 $422
2009 $333
United Therapeutics Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $412
2024-12-31 $378
2024-09-30 $406
2024-06-30 $395
2024-03-31 $321
2023-12-31 $355
2023-09-30 $282
2023-06-30 $283
2023-03-31 $223
2022-12-31 $316
2022-09-30 $202
2022-06-30 $265
2022-03-31 $174
2021-12-31 $245
2021-09-30 $216
2021-06-30 $224
2021-03-31 $444
2020-12-31 $320
2020-09-30 $159
2020-06-30 $222
2020-03-31 $190
2019-12-31 $248
2019-09-30 $218
2019-06-30 $152
2019-03-31 $1,019
2018-12-31 $250
2018-09-30 $263
2018-06-30 $227
2018-03-31 $82
2017-12-31 $326
2017-09-30 $122
2017-06-30 $356
2017-03-31 $107
2016-12-31 $235
2016-09-30 $170
2016-06-30 $127
2016-03-31 $5
2015-12-31 $250
2015-09-30 $-1
2015-06-30 $175
2015-03-31 $342
2014-12-31 $168
2014-09-30 $362
2014-06-30 $146
2014-03-31 $73
2013-12-31 $318
2013-09-30 $198
2013-06-30 $158
2013-03-31 $151
2012-12-31 $115
2012-09-30 $162
2012-06-30 $120
2012-03-31 $97
2011-12-31 $132
2011-09-30 $99
2011-06-30 $69
2011-03-31 $126
2010-12-31 $145
2010-09-30 $106
2010-06-30 $74
2010-03-31 $97
2009-12-31 $100
2009-09-30 $85
2009-06-30 $88
2009-03-31 $59
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.078B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.929B 32.24
Zoetis (ZTS) United States $70.240B 26.21
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Daiichi Sankyo, - (DSNKY) Japan $44.148B 22.63
BeOne Medicines - (ONC) Cayman Islands $29.241B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.170B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Summit Therapeutics (SMMT) United States $15.537B 0.00
Shionogi (SGIOY) Japan $14.870B 14.90
Neurocrine Biosciences (NBIX) United States $12.685B 43.45
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $8.141B 66.18
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Madrigal Pharmaceuticals (MDGL) United States $6.327B 0.00
Ionis Pharmaceuticals (IONS) United States $6.309B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.872B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.897B 0.00
Hypermarcas (HYPMY) Brazil $2.850B 18.75
Catalyst Pharmaceuticals (CPRX) United States $2.692B 9.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
BioCryst Pharmaceuticals (BCRX) United States $2.078B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.066B 0.00
Indivior (INDV) United States $1.919B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $1.896B 0.00
ARS Pharmaceuticals (SPRY) United States $1.648B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.449B 0.00
Ocular Therapeutix (OCUL) United States $1.448B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Dyne Therapeutics (DYN) United States $1.208B 0.00
Harrow (HROW) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.088B 21.76
Enliven Therapeutics (ELVN) United States $1.038B 0.00
Verve Therapeutics (VERV) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.967B 5.22
Akebia Therapeutics (AKBA) United States $0.964B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.929B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Liminatus Pharma (LIMN) United States $0.694B 0.00
Xencor (XNCR) United States $0.589B 0.00
Altimmune (ALT) United States $0.583B 0.00
KalVista Pharmaceuticals (KALV) United States $0.582B 0.00
USANA Health Sciences (USNA) United States $0.572B 12.43
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Relay Therapeutics (RLAY) United States $0.567B 0.00
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Bioventus (BVS) United States $0.555B 14.08
Theravance Biopharma (TBPH) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
AleAnna (ANNA) United States $0.484B 0.00
Siga Technologies (SIGA) United States $0.457B 9.55
Oruka Therapeutics (ORKA) United States $0.440B 0.00
Organogenesis (ORGO) United States $0.439B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.03
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 25.59
Tonix Pharmaceuticals Holding (TNXP) United States $0.262B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
MediWound (MDWD) Israel $0.211B 0.00
OmniAb (OABI) United States $0.209B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Larimar Therapeutics (LRMR) United States $0.191B 0.00
ProKidney (PROK) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Champions Oncology (CSBR) United States $0.108B 17.68
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 36.67
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Scienture Holdings (SCNX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00